- The α-galactosidase type A gene aglA from Aspergillus niger encodes a fully functional α-N-acetylgalactosaminidase2010 | Faculty of Science
- Biochemistry of Fabry Disease2010 | First Faculty of Medicine
- Defects in degradation of blood group A and B glycosphingolipids in Schindler and Fabry diseases2002 | First Faculty of Medicine
- Complex Vascular Involvement in Fabry Disease: An Unusual Case of Combined Critical Lower Limb Ischemia and Deep Vein Thrombosis2016 | First Faculty of Medicine
- Fabry disease and its cardiac involvement2018 | First Faculty of Medicine
- Narrative review on Morbus Fabry: diagnosis and management of cardiac manifestations2021 | First Faculty of Medicine
- Screening of Fabry disease in patients with an implanted permanent pacemaker2023 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Time to treatment benefit for adult patients with Fabry disease receiving agalsidase beta: Data from the Fabry Registry2016 | First Faculty of Medicine
- Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic2022 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study2023 | First Faculty of Medicine
- Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study2023 | First Faculty of Medicine